| Stage | CWST | % of rev | AGYS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $544M | 100.00% | $83M | 100.00% | CWST ×6.56 |
| Gross profit | $179M | 32.88% | $53M | 64.40% | AGYS +31.5pp |
| Operating income | $20M | 3.67% | $13M | 15.21% | AGYS +11.5pp |
| Pre-tax income | $3M | 0.62% | $15M | 18.04% | AGYS +17.4pp |
| Net income | $4M | 0.69% | $12M | 14.82% | AGYS +14.1pp |
| Stage | CWST | AGYS | Gap · A − B |
|---|---|---|---|
| Revenue | $544M100.00% | $83M100.00% | CWST ×6.56 |
| Gross profit | 32.88%$179M | 64.40%$53M | AGYS +31.5pp |
| Operating income | 3.67%$20M | 15.21%$13M | AGYS +11.5pp |
| Pre-tax income | 0.62%$3M | 18.04%$15M | AGYS +17.4pp |
| Net income |
| 0.69%$4M |
| 14.82%$12M |
| AGYS +14.1pp |
No disclosed counterparties: AGYS.
None